Comprehensive genomic profiling (CGP) of clinical T2-4N0M0 muscle-invasive bladder cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatin-based chemotherapy before radical cystectomy (RC).

Autor: Mercinelli, Chiara, Raggi, Daniele, Cigliola, Antonio, Tateo, Valentina, Patanè, Damiano Alfio, Crupi, Emanuele, Colecchia, Maurizio, Moschini, Marco, Re, Chiara, Avesani, Giulio, Briganti, Alberto, Montorsi, Francesco, Ross, Jeffrey S., Graf, Ryon, Pavlick, Dean C., Necchi, Andrea
Zdroj: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p653-653, 193p
Databáze: Supplemental Index